GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (Q17P71)

Analyse AlphaFold monomer V2.0 prediction for tryptophan 2,3-dioxygenase (Q17P71) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q17P71
Type
protein
Length
393 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xc4c27773Fe1F9E993e353448F6CC683426A69bdd
Molecule
Tryptophan 2,3-dioxygenase
UniProt
Q17P71
Pockets
2 · best druggability 0.80

Structure

1 distinct chain · 65% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATryptophan 2,3-dioxygenaseprotein39365% helix, 0% strandQ17P71

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15130.800.8645empty
21450.530.8019empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.